IR-MED Appoints Richard Serbin, Esq. to its Advisory Board

  Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent attorney for Schering Plough Pharmacist, FDA regulatory attorney, and patent attorney with 40+ years of professional service and 25+ years of experience in the pharmaceutical industry and investment community Rosh Pina, Israel, Sept. 13, 2023 (GLOBE NEWSWIRE) — IR-MED Inc., (“IR-MED” or […]

IRME: Initiating coverage of IR-Med, Inc., a development stage medical device company that is creating a technology platform for non-invasive devices to be used as a decision support system tool (DSS)

By Thomas Kerr, CFA   We are initiating coverage of IR-Med, Inc. (OTC:IRME), a development stage medical device company that is creating a technology platform for non-invasive devices to be used as a decision support system tool (DSS) for various medical indications by detecting and measuring various biomarkers and molecules in blood and human tissue in […]

IR-MED Chairman & Interim CEO Issues Letter to Shareholders

Dear Shareholders, On behalf of the Board and entire the team at IR MED, we thank you for being a long term shareholder of our company. Your trust in our ability to execute on a multi-billion opportunity is appreciated and it is our hope that you will be well-rewarded. As you may well be aware, […]


Whether you call them bedsores, pressure ulcers or pressure injuries (PI), they’re a serious healthcare risk to people confined to a bed or chair and to people with diabetes and poor circulation. The red, painful sores often affect heels, ankles, hips and tailbone. They can become infected and extend into the muscle and bone if not caught […]

IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries

Early detection of pressure injuries can be challenging for minority populations due to the current method of visual inspection Patients with dark skin tones suffered more than twice as much as those with lighter skin, evidencing a major health inequality in the U.S. Dr. Dalton, a visionary healthcare thought leader and hall of fame CEO, is supporting IR-Med in analyzing the benefits of the PressureSafe […]

IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device

Innovative executive driving positive outcomes and profitability, Dr. Eschenbacher is focused on addressing healthcare access and equity Through early, non-invasive detection of pressure injuries, PressureSafe is poised to save billions in acute care costs and reduce patient deaths from pressure wounds Rosh Pina, Israel, June 07, 2023 (GLOBE NEWSWIRE) — IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive AI-driven spectrographic analysis technology […]

IR-Med to present at National Pressure Injury Advisory Panel 2023

The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) — “IR-MED” or the “Company”) (OTCQB:IRME), will be presenting its proprietary technology that is being designed to detect early-stage Pressure Injuries (PI) at the Annual Conference of the National Pressure […]

Biotech In 2023: Making Its Mark On The Future Of Healthcare

Technology continues to be the driving force behind new generations of innovation—and the healthcare field is not immune to its impact, especially when it comes to the accuracy and efficiency that artificial intelligence is bringing to biotechnology. Life-saving drugs developed at record speed, advancements in gene editing breakthroughs that inform more efficacious preventive care regimes, […]